Selected research
Industry Research
Tablet and Capsule Budesonide Industry Research Report 2026
Market perspective
The global Tablet and Capsule Budesonide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tablet and Capsule Budesonide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tablet and Capsule Budesonide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tablet and Capsule Budesonide include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Orion Corporation, Salix, AstraZeneca, Synmosa Biopharma, Lunan Better Pharma and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tablet and Capsule Budesonide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tablet and Capsule Budesonide Market by Company
Chiesi Farmaceutici
Cipla
Cosmo Pharmaceuticals
Orion Corporation
Salix
AstraZeneca
Synmosa Biopharma
Lunan Better Pharma
Mylan
Sandoz
Shanghai Sine Promod
Teva
Tablet and Capsule Budesonide Segment by Type
Tablet
Capsule
Tablet and Capsule Budesonide Segment by Application
Inflammatory Bowel Disease Treatment
Respiratory Disease Treatment
Nose Disease Treatment
Other
Tablet and Capsule Budesonide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet and Capsule Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tablet and Capsule Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet and Capsule Budesonide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tablet and Capsule Budesonide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tablet and Capsule Budesonide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tablet and Capsule Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
Applications
- Inflammatory Bowel Disease Treatment
- Respiratory Disease Treatment
- Nose Disease Treatment
- Other
Companies covered
- Chiesi Farmaceutici
- Cipla
- Cosmo Pharmaceuticals
- Orion Corporation
- Salix
- AstraZeneca
- Synmosa Biopharma
- Lunan Better Pharma
- Mylan
- Sandoz
- Shanghai Sine Promod
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tablet and Capsule Budesonide Market Size (2021-2032)
- 2.2.2 Global Tablet and Capsule Budesonide Sales (2021-2032)
- 2.2.3 Global Tablet and Capsule Budesonide Market Average Price (2021-2032)
- 2.3 Tablet and Capsule Budesonide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.4 Tablet and Capsule Budesonide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Inflammatory Bowel Disease Treatment
- 2.4.3 Respiratory Disease Treatment
- 2.4.4 Nose Disease Treatment
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tablet and Capsule Budesonide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tablet and Capsule Budesonide Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tablet and Capsule Budesonide Revenue of Manufacturers (2021-2026)
- 3.4 Global Tablet and Capsule Budesonide Average Price by Manufacturers (2021-2026)
- 3.5 Global Tablet and Capsule Budesonide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tablet and Capsule Budesonide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tablet and Capsule Budesonide, Product Type & Application
- 3.8 Global Manufacturers of Tablet and Capsule Budesonide, Established Date
- 3.9 Global Tablet and Capsule Budesonide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chiesi Farmaceutici
- 4.1.1 Chiesi Farmaceutici Company Information
- 4.1.2 Chiesi Farmaceutici Business Overview
- 4.1.3 Chiesi Farmaceutici Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio
- 4.1.5 Chiesi Farmaceutici Recent Developments
- 4.2 Cipla
- 4.2.1 Cipla Company Information
- 4.2.2 Cipla Business Overview
- 4.2.3 Cipla Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Tablet and Capsule Budesonide Product Portfolio
- 4.2.5 Cipla Recent Developments
- 4.3 Cosmo Pharmaceuticals
- 4.3.1 Cosmo Pharmaceuticals Company Information
- 4.3.2 Cosmo Pharmaceuticals Business Overview
- 4.3.3 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio
- 4.3.5 Cosmo Pharmaceuticals Recent Developments
- 4.4 Orion Corporation
- 4.4.1 Orion Corporation Company Information
- 4.4.2 Orion Corporation Business Overview
- 4.4.3 Orion Corporation Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Orion Corporation Tablet and Capsule Budesonide Product Portfolio
- 4.4.5 Orion Corporation Recent Developments
- 4.5 Salix
- 4.5.1 Salix Company Information
- 4.5.2 Salix Business Overview
- 4.5.3 Salix Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Salix Tablet and Capsule Budesonide Product Portfolio
- 4.5.5 Salix Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Tablet and Capsule Budesonide Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
- 4.7 Synmosa Biopharma
- 4.7.1 Synmosa Biopharma Company Information
- 4.7.2 Synmosa Biopharma Business Overview
- 4.7.3 Synmosa Biopharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio
- 4.7.5 Synmosa Biopharma Recent Developments
- 4.8 Lunan Better Pharma
- 4.8.1 Lunan Better Pharma Company Information
- 4.8.2 Lunan Better Pharma Business Overview
- 4.8.3 Lunan Better Pharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio
- 4.8.5 Lunan Better Pharma Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Tablet and Capsule Budesonide Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Tablet and Capsule Budesonide Product Portfolio
- 4.10.5 Sandoz Recent Developments
- 4.11 Shanghai Sine Promod
- 4.11.1 Shanghai Sine Promod Company Information
- 4.11.2 Shanghai Sine Promod Business Overview
- 4.11.3 Shanghai Sine Promod Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio
- 4.11.5 Shanghai Sine Promod Recent Developments
- 4.12 Teva
- 4.12.1 Teva Company Information
- 4.12.2 Teva Business Overview
- 4.12.3 Teva Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Tablet and Capsule Budesonide Product Portfolio
- 4.12.5 Teva Recent Developments
5 Global Tablet and Capsule Budesonide Market Scenario by Region
- 5.1 Global Tablet and Capsule Budesonide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tablet and Capsule Budesonide Sales by Region: 2021-2032
- 5.2.1 Global Tablet and Capsule Budesonide Sales by Region: 2021-2026
- 5.2.2 Global Tablet and Capsule Budesonide Sales by Region: 2027-2032
- 5.3 Global Tablet and Capsule Budesonide Revenue by Region: 2021-2032
- 5.3.1 Global Tablet and Capsule Budesonide Revenue by Region: 2021-2026
- 5.3.2 Global Tablet and Capsule Budesonide Revenue by Region: 2027-2032
- 5.4 North America Tablet and Capsule Budesonide Market Facts & Figures by Country
- 5.4.1 North America Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tablet and Capsule Budesonide Sales by Country (2021-2032)
- 5.4.3 North America Tablet and Capsule Budesonide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tablet and Capsule Budesonide Market Facts & Figures by Country
- 5.5.1 Europe Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tablet and Capsule Budesonide Sales by Country (2021-2032)
- 5.5.3 Europe Tablet and Capsule Budesonide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Tablet and Capsule Budesonide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tablet and Capsule Budesonide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tablet and Capsule Budesonide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tablet and Capsule Budesonide Market Facts & Figures by Country
- 5.7.1 South America Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tablet and Capsule Budesonide Sales by Country (2021-2032)
- 5.7.3 South America Tablet and Capsule Budesonide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tablet and Capsule Budesonide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tablet and Capsule Budesonide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tablet and Capsule Budesonide Sales by Type (2021-2032)
- 6.1.1 Global Tablet and Capsule Budesonide Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tablet and Capsule Budesonide Sales Market Share by Type (2021-2032)
- 6.2 Global Tablet and Capsule Budesonide Revenue by Type (2021-2032)
- 6.2.1 Global Tablet and Capsule Budesonide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tablet and Capsule Budesonide Revenue Market Share by Type (2021-2032)
- 6.3 Global Tablet and Capsule Budesonide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tablet and Capsule Budesonide Sales by Application (2021-2032)
- 7.1.1 Global Tablet and Capsule Budesonide Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tablet and Capsule Budesonide Sales Market Share by Application (2021-2032)
- 7.2 Global Tablet and Capsule Budesonide Revenue by Application (2021-2032)
- 7.2.1 Global Tablet and Capsule Budesonide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tablet and Capsule Budesonide Revenue Market Share by Application (2021-2032)
- 7.3 Global Tablet and Capsule Budesonide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tablet and Capsule Budesonide Value Chain Analysis
- 8.1.1 Tablet and Capsule Budesonide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tablet and Capsule Budesonide Production Mode & Process
- 8.2 Tablet and Capsule Budesonide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tablet and Capsule Budesonide Distributors
- 8.2.3 Tablet and Capsule Budesonide Customers
9 Global Tablet and Capsule Budesonide Analyzing Market Dynamics
- 9.1 Tablet and Capsule Budesonide Industry Trends
- 9.2 Tablet and Capsule Budesonide Industry Drivers
- 9.3 Tablet and Capsule Budesonide Industry Opportunities and Challenges
- 9.4 Tablet and Capsule Budesonide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst